AMCP CEO Blog: As managed care pharmacy professionals, we work to improve the lives of millions of people. But we also must never forget that behind these large numbers are individual patients.
AMCP CEO Blog: This truism lies at the heart of much of what managed care pharmacy does. AMCP members and their organizations have long championed the use of preventive-care services to achieve better health outcomes and lower overall health care costs.
AMCP webinar that reviewed proceedings from this Partnership Forum.
Press Release: Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE has been appointed to the Pharmacy Quality Alliance (PQA) 2018-2019 Board of Directors.
AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
The Academy of Managed Care Pharmacy thanks the Centers for Medicare and Medicaid Services (CMS) for the opportunity to comment on the Proposed Rule, Medicare Program; CY 2018 Updates to the Quality Payment Program (the Proposed Rule).
AMCP webinar that reviewed proceedings from this Partnership Forum.
Partnership Forum: The event brought industry leaders to together in November 2016, focused on the need to drive better value and outcomes in oncology for patients, providers, payers and delivery networks.
AMCP CEO Blog: People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for MTM services.
AMCP CEO Blog: Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15).
The undersigned pharmacist organizations thank the Food and Drug Administration (FDA) for the opportunity to provide comments on the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FY) 2018 through 2022 as published in the Federal Register on July 19, 2016. Collectively, our organizations represent over 100,000 pharmacists across the full spectrum of health care practice settings.
